17 Mar MEDIA RELEASE: Atomo Diagnostics Issues Supplementary IPO Prospectus in Response to Multiple COVID-19 Rapid Blood Test Requests 

SYDNEY Australia, 17 March 2020: Australian rapid blood test company Atomo Diagnostics Limited (ACN 142 925 6840) said today it was working with potential OEM customers to develop rapid self-tests for COVID-19 that could deliver results to patients in as little as 15 minutes, and be...